2011

Boehringer-Ingelheim (BI) stands out in its attempt to stand out from the social(ist) cookie-cutter crowd of pharma FB pages. Shows what you can do with dedicated resources and creativity.

Welcome to Volume 10, Issue #19 (21 DECEMBER 2011) of Pharma Marketing News.

Is Your Brand a Digital Genius or a Feeble-Minded Idiot? When it comes to digital IQ, some brands are geniuses and some are feeble-minded idiots, according to the 'L2 Digital IQ Index' for pharmaceutical brands, a first-of-its kind measurement of the digital competence of 51 pharma brands across eight therapeutic categories.

The authors of a physician survey published in the November 8, 2010, issue of Archives of Internal Medicine conclude 'given that 83.8% of physicians have PIRs, it is clear that industry still has substantial financial links with the nation's physicians. These findings support the ongoing need for a national system of disclosure of PIRs [Physician-Drug Industry Relationships].' Such a system is part of the Physician Sunshine Law, which is scheduled to go into effect in 2012 with public disclosure of payments scheduled to begin September, 2013.

Many critics of pharma-supported CME believe this support leads to bias. Between 9 May 2011 and 13 September 2011, readers of Pharma Marketing News were asked to answer a few short questions relating to potential bias in industry-supported CME programs and how to limit the need for industry funding of CME. The results are summarized in this article.

No doubt you've heard that as of August 15, 2011, Facebook opened up comments on ALL pharma pages with some exceptions. That means that the pharmaceutical industry will no longer be able to shut off comments on their Facebook pages.

Every year without fail there are revelations about pharmaceutical companies behaving badly -- companies that have been charged with crimes such as making kickbacks to physicians, engaging in Medicare and Medicaid fraud, promoting products off label to physicians or companies that are called to testify before Congress about sub par manufacturing practices. 2010 seems to be unique in the number of companies behaving badly.

Welcome to Volume 10, Issue #5 (10 MARCH 2011) of Pharma Marketing News.

This article focuses on Adobe Connect for eDetailing, a specific collaboration between Adobe and ConnectSolutions, a leading provider of private cloud deployments of web conferencing and collaboration solutions.

Direct-to-Consumer (DTC) pharmaceutical advertising spending suffered a 'double dip' recession between 2007 and 2010, according to data presented in the AdAge Insights Whitepaper